Extract from the Clinical Evaluation Report for Olmesartan ...

Unsurprisingly, the simulation results also indicated that blood pressure lowering effects of CS-8635 triple combination therapies were superior to their respective mono and dual treatment of the olmesartan, amlodipine and HCT, and the predicted systolic and diastolic blood pressure lowering effects were in order of 20/5/12.5 mg < 40/5/12.5 mg ... ................
................